PTJ
NXTM

Paul Tudor Jones’s NxStage Medical Inc. NXTM Stock Holding History

Paul Tudor Jones’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,876
Closed -$233K – 1634
2016
Q4 		$233K Buy
+8,876
New +$220K 0.01% 1151
2016
Q3 		– Sell
-14,241
Closed -$309K – 1855
2016
Q2 		$309K Buy
+14,241
New +$254K 0.01% 1147
2015
Q3 		– Sell
-16,200
Closed -$231K – 1850
2015
Q2 		$231K Buy
+16,200
New +$274K 0.01% 1267
2014
Q1 		– Sell
-20,600
Closed -$206K – 1505
2013
Q4 		$206K Buy
+20,600
New +$234K 0.01% 1097

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Paul Tudor Jones's NXTM Position: Q1 2017 in Review

Paul Tudor Jones sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 8,876 shares — an estimated $233K sold.

Paul Tudor Jones first reported a position in NXTM in Q4 2013 and held it in 4 quarters. The position peaked at $309K in Q2 2016. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

  • Paul Tudor Jones reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 8,876 NxStage Medical Inc. shares in Q1 2017, an estimated $233K.
  • Paul Tudor Jones first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 4 quarters.
  • Paul Tudor Jones's NxStage Medical Inc. position peaked at $309K in Q2 2016.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on Tudor Investment Corp's 13F filing for Q1 2017, filed 15 May 2017.